Isoxsuprine%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520hydrochloride

# Isoxsuprine hydrochloride ## Overview Isoxsuprine hydrochloride is a vasodilator believed to act by relaxing vascular smooth muscle, leading to peripheral vasodilation. Its efficacy for its primary indications is not well-established by rigorous clinical trials. ## Primary Indications * Treatment of peripheral vascular diseases such as arteriosclerosis obliterans, diabetes mellitus with peripheral vascular complications, and thromboangiitis obliterans (Buerger's disease). * Management of intermittent claudication. ## Adult Dosing * **Oral:** 10 mg to 20 mg three to four times daily. * **Maximum:** Not explicitly defined, but higher doses are typically not associated with increased efficacy. ## Pediatric Dosing There is no established pediatric dosing for isoxsuprine hydrochloride. ## Dose Adjustments No specific dose adjustments are recommended for renal or hepatic impairment, but caution and lower doses may be considered due to potential accumulation. ## Contraindications * Hypersensitivity to isoxsuprine hydrochloride. * Patients in whom vasodilation is undesirable (e.g., those with severe hypotension or tachycardia). ## Adverse Effects * **Common:** Flushing, hypotension, dizziness, weakness, headache, nausea, vomiting, abdominal distress, rash. * **Less Common:** Tachycardia, nervousness, drowsiness. ## Key Drug Interactions * **Antihypertensives:** Isoxsuprine may potentiate the hypotensive effects of antihypertensive medications. * **Other Vasodilators:** Additive hypotensive effects may occur. ## Monitoring * Blood pressure and heart rate. * Signs and symptoms of peripheral vascular disease (e.g., claudication distance, skin temperature, color, and pulses). * Patient's response to therapy. ## Clinical Pearls * The clinical benefit of isoxsuprine hydrochloride for peripheral vascular disease is controversial and not strongly supported by evidence. * Initiate therapy at the lowest effective dose and titrate as needed. * Advise patients to rise slowly from sitting or lying positions to minimize orthostatic hypotension. * Discontinue if adverse effects are bothersome or if no improvement is noted. *** **Disclaimer:** This information is intended for clinical use and does not replace professional medical judgment. Always consult the most current prescribing information and relevant literature for complete details and to verify dosages and safety information.